[奥曲肽在肝素诱导的血小板减少症血液透析中的价值] - Suppr | 超能文献

[Value of orgaran in hemodialysis during heparin-induced thrombopenia].

作者信息

Lamriben L, Tiberghien F, Delacour J L, Floriot C, Wagschal G, Daoudal P, Ory J P

出版信息

Presse Med. 1996 Sep 28;25(28):1303.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Value of orgaran in hemodialysis during heparin-induced thrombopenia].[奥曲肽在肝素诱导的血小板减少症血液透析中的价值]

Presse Med. 1996 Sep 28;25(28):1303.

2

Failure of Orgaran therapy in a patient with a previous heparin-induced thrombocytopenia syndrome.奥加诺治疗对一名既往有肝素诱导的血小板减少综合征患者无效。

Br J Haematol. 1995 Aug;90(4):969-70. doi: 10.1111/j.1365-2141.1995.tb05229.x.

3

Heparin-induced thrombocytopenia type II: successful use of Orgaran (ORG 10172) in intensive care patients.II型肝素诱导的血小板减少症：在重症监护患者中成功使用奥加诺（ORG 10172）

Intensive Care Med. 1995 Jun;21(6):542-3. doi: 10.1007/BF01706210.

4

Heparin-induced thrombocytopenia in hemodialysis patients.血液透析患者中的肝素诱导的血小板减少症。

Nephrol Nurs J. 2000 Apr;27(2):240-1, 213.

5

Treatment of heparin-induced thrombocytopenia.肝素诱导的血小板减少症的治疗。

J Thorac Cardiovasc Surg. 1997 Sep;114(3):517-8. doi: 10.1016/S0022-5223(97)70219-8.

6

[Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia].[达那肝素钠的临床经验。肝素诱导的血小板减少症的应对措施]

Anaesthesist. 1998 Nov;47(11 Suppl Massnahmen):1-4.

7

Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia.在肝素诱导的血小板减少症情况下旋磨术期间使用奥曲肽。

Cathet Cardiovasc Diagn. 1998 Nov;45(3):318-22. doi: 10.1002/(sici)1097-0304(199811)45:3<318::aid-ccd23>3.0.co;2-2.

8

[Danaparoid (orgaran) for continuous venovenous hemodiafiltration in a patient with heparin-induced thrombocytopenia].[达那肝素（奥加兰）用于肝素诱导的血小板减少症患者的持续静脉-静脉血液透析滤过治疗]

Ann Fr Anesth Reanim. 1998;17(1):82-3. doi: 10.1016/s0750-7658(97)80191-8.

9

Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.肝素诱导的血小板减少症患者在体外循环期间使用达那肝素。

J Cardiothorac Vasc Anesth. 2000 Dec;14(6):707-9. doi: 10.1053/jcan.2000.18531.

10

[Heparin-induced thrombopenia during hemodialysis in intensive care: use of a low molecular weight heparinoid, ORG 10172 (Orgaran)].重症监护中血液透析期间肝素诱导的血小板减少症：低分子肝素类似物ORG 10172（奥加诺）的应用

Ann Fr Anesth Reanim. 1995;14(1):29-32. doi: 10.1016/s0750-7658(05)80146-7.

引用本文的文献

1

Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.达那肝素。其药理学及在肝素诱导的血小板减少症管理中的临床应用综述。

Drugs. 1997 Dec;54(6):903-24. doi: 10.2165/00003495-199754060-00008.